Skip to content
OpenCapital
Get started

MoonLake Immunotherapeutics MLTX Operating Income

Discontinued — last reported Q1 '26

Operating Income at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$36.43M-45.2%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$34.64M-25.8%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$39.05M+12.3%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$41.42M+89.6%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-$84.15M-13.1%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
-$9.09M+62.9%

Other financials

Income statement

See full
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.56B-45.9%
Enterprise value$1.36B-50.0%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's operating income?
MoonLake Immunotherapeutics (MLTX) reported operating income of -$70.02M in Q1 2026.
How has MoonLake Immunotherapeutics's operating income changed year-over-year?
MoonLake Immunotherapeutics's operating income decreased by 47.5% year-over-year, from -$47.49M to -$70.02M.
What is the long-term trend for MoonLake Immunotherapeutics's operating income?
Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's operating income has grown at a 27.5% compound annual growth rate (CAGR), from -$92.62M to -$244.84M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.